GO:0048273 mitogen-activated protein kinase p38 binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048273 (mitogen-activated protein kinase p38 binding) is a molecular function describing the selective, non-covalent interaction of a protein with the p38 MAP kinase, the stress-activated kinase whose crystal structure was solved by Wilson et al. in 1996.
• p38 binding partners include AU-rich element-binding proteins that stabilize mRNAs, as shown for the p38 pathway-mediated mRNA stabilization described by Dean et al. and for Hog1p/p38 regulation of AU-rich-element-bearing MFA2 translation.
• Binding to p38 is dynamic and regulated; Kumar et al. showed that p38 activation and regulation involve conformational and docking-site changes that control substrate engagement.
• p38 binding underlies diverse physiology, including hepatic gluconeogenesis, hypertrophic chondrocyte HDAC4 degradation, and keratin-dependent Hsp70-mediated nuclear localization of p38.
• The p38 binding interface is a validated drug target, and structure-activity relationships of p38 inhibitors have been extensively reviewed.
• CRISPR knockout, point-mutation, knock-in and overexpression models, combined with biochemical binding assays, are the core tools for dissecting GO:0048273 in disease-relevant cells.
Description
GO:0048273, mitogen-activated protein kinase p38 binding, is a molecular function term in the Gene Ontology that describes the binding of a protein to mitogen-activated protein kinase p38, an enzyme that catalyzes the transfer of phosphate from ATP to hydroxyl side chains on proteins in response to mitogen activation. The p38 MAP kinase is a stress-activated serine/threonine kinase whose three-dimensional structure was determined by X-ray crystallography, revealing the ATP-binding cleft and the docking surfaces that mediate partner recognition. Because p38 signaling depends on the recruitment of specific binding partners, GO:0048273 captures a critical node that converts extracellular stress into downstream phosphorylation events. Researchers study p38 binding because it determines which substrates, scaffolds and regulatory proteins are engaged during stress, inflammation and metabolic signaling. For example, AU-rich element-binding proteins are recruited in a p38-dependent manner to stabilize labile transcripts, and p38/Hog1p controls translation of AU-rich-element-bearing mRNAs such as MFA2. Binding events also control p38 localization: keratins regulate Hsp70-mediated nuclear localization of p38, linking cytoskeletal architecture to kinase trafficking. In hypertrophic chondrocytes, p38 binding and activity drive HDAC4 degradation, a process relevant to skeletal development. From a translational perspective, the p38 binding interface is druggable, and structure-activity relationships of p38 inhibitors have been reviewed in detail. p38 signaling also contributes to hepatic gluconeogenesis, making p38 binding partners attractive targets for metabolic disease research. This article integrates the QuickGO definition with verified PubMed literature to explain the mechanism, key genes, disease links and experimental methods used to study GO:0048273.
mitogen-activated protein kinase p38 binding At A Glance
| GO ID | GO:0048273 |
|---|---|
| GO term | mitogen-activated protein kinase p38 binding |
| Ontology | molecular_function |
| Synonym | MAPK p38 binding |
| Definition | Binding to mitogen-activated protein kinase p38, an enzyme that catalyzes the transfer of phosphate from ATP to hydroxyl side chains on proteins in response to mitogen activation. |
| Major function | Recognition and non-covalent interaction with p38 MAP kinase to enable substrate recruitment, scaffolding and signal transduction. |
| Representative partners | AU-rich element-binding proteins, HDAC4, Hsp70/keratin complexes and other p38 pathway components. |
| Cellular context | Stress-activated signaling, mRNA stabilization, translation control and nuclear translocation. |
| Therapeutic relevance | p38 binding interfaces are targeted by small-molecule inhibitors with defined structure-activity relationships. |
What Is GO:0048273?
In simple terms, GO:0048273 describes the physical, non-covalent binding of a protein to the p38 mitogen-activated protein kinase. The QuickGO definition states: Binding to mitogen-activated protein kinase p38, an enzyme that catalyzes the transfer of phosphate from ATP to hydroxyl side chains on proteins in response to mitogen activation. This molecular function is therefore about recognition and interaction with p38 rather than about catalysis by the binding partner itself. The interaction can occur through docking grooves, hydrophobic patches or linear motifs on p38, and it is the first step that positions substrates, scaffolds or regulators for p38-dependent phosphorylation.
Why Is mitogen-activated protein kinase p38 binding Important in Cell Biology?
GO:0048273 matters because the binding of proteins to p38 MAP kinase is the decision point that determines whether a cell mounts a stress, inflammatory or metabolic response. p38 itself is a kinase that transfers phosphate from ATP to hydroxyl side chains on proteins following mitogen activation, and its crystal structure revealed the architectural features that allow selective partner binding. Dynamic activation and regulation studies show that p38 engagement is not a simple on/off switch but a finely tuned process involving docking and conformational changes. Functionally, p38 binding underlies mRNA stabilization through AU-rich element-binding proteins, translation of AU-rich-element-bearing transcripts, nuclear localization of p38 via keratins and Hsp70, HDAC4 degradation in hypertrophic chondrocytes and hepatic gluconeogenesis. Because these processes are central to inflammation, metabolism and tissue remodeling, and because p38 inhibitors have been extensively characterized, understanding GO:0048273 is essential for both basic and translational research.
• Defines the molecular recognition step that recruits substrates and regulators to p38 MAP kinase.
• Controls mRNA stability through AU-rich element-binding proteins in the p38 pathway.
• Regulates translation of AU-rich-element-bearing transcripts such as MFA2 via p38/Hog1p.
• Mediates nuclear localization of p38 through keratin and Hsp70-dependent mechanisms.
• Drives HDAC4 degradation in hypertrophic chondrocytes, linking p38 binding to skeletal biology.
• Contributes to hepatic gluconeogenesis, connecting p38 binding to metabolic disease.
• Provides a structural basis for drug design, as reviewed for p38 inhibitors.
• Is experimentally tractable using recombinant p38, binding assays and CRISPR-engineered cell models.
Molecular Mechanism of mitogen-activated protein kinase p38 binding
Structural basis of p38 recognition
In simple terms: p38 has a shape that lets partner proteins dock into specific pockets.
The crystal structure of p38 MAP kinase revealed a bilobal kinase fold with an ATP-binding cleft and surface grooves that serve as docking sites for interacting proteins. These structural features explain how binding partners achieve selectivity for p38 over other MAP kinases. The same surfaces are exploited by small-molecule inhibitors, whose structure-activity relationships have been reviewed. Because binding is non-covalent and reversible, it can be modulated by conformational changes during activation.
Dynamic activation and regulation of p38 binding
In simple terms: p38 binding is not static; it changes as the kinase is switched on and off.
Kumar et al. showed that p38 activation and regulation involve dynamic conformational transitions that affect how binding partners engage the kinase. This means GO:0048273 should be viewed as a regulated interaction rather than a fixed property. The dynamic nature of p38 binding helps explain why the same kinase can interact with different partners in different cellular contexts, from mRNA stabilization to nuclear translocation.
Binding to AU-rich element-binding proteins and mRNA stabilization
In simple terms: p38 binding helps hold onto proteins that keep short-lived mRNAs alive.
Dean et al. demonstrated that AU-rich element-binding proteins are involved in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilization. In this context, binding to p38 or to p38-pathway components positions AU-rich element-binding proteins to protect labile transcripts. A related study showed that p38/Hog1p regulates translation of the AU-rich-element-bearing MFA2 transcript, further linking p38 binding to post-transcriptional control. These findings place GO:0048273 at the interface of signal transduction and RNA regulation.
Binding partners in localization and degradation
In simple terms: p38 binding can move the kinase into the nucleus or trigger destruction of other proteins.
Keratins regulate Hsp70-mediated nuclear localization of p38, showing that binding interactions control where p38 accumulates in the cell. In hypertrophic chondrocytes, p38 induces HDAC4 degradation, a process that depends on p38-pathway binding and activity. Together, these examples show that GO:0048273 encompasses interactions that determine p38 localization and the fate of downstream targets.
Metabolic and physiological output of p38 binding
In simple terms: p38 binding ultimately changes how the body handles glucose and other metabolic tasks.
Cao et al. showed that p38 mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis. This physiological output depends on p38 engaging binding partners that relay the signal to metabolic gene expression. Thus, GO:0048273 is not only a biochemical event but also a determinant of organism-level metabolism, making it relevant to diabetes and metabolic syndrome research.
Key Genes Involved in GO:0048273 mitogen-activated protein kinase p38 binding
The following genes and proteins are experimentally linked to p38 MAP kinase binding and its downstream biology, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAPK14 | Encodes p38 alpha MAP kinase, the core kinase in GO:0048273 | Central to p38 binding assays and inhibitor studies |
| MAPK11 | Encodes p38 beta MAP kinase, a p38 family member | Comparative binding selectivity studies |
| MAPK12 | Encodes p38 gamma MAP kinase, a p38 family member | Tissue-specific p38 binding research |
| MAPK13 | Encodes p38 delta MAP kinase, a p38 family member | Stress-response binding studies |
| HSPA1A | Hsp70 chaperone involved in p38 nuclear localization | Keratin-Hsp70-p38 localization models |
| KRT8 | Keratin that regulates Hsp70-mediated p38 nuclear localization | Cytoskeleton-p38 trafficking studies |
| KRT18 | Keratin partner in p38 localization regulation | Epithelial p38 binding models |
| HDAC4 | Histone deacetylase degraded downstream of p38 in chondrocytes | Hypertrophic chondrocyte models |
| ELAVL1 | AU-rich element-binding protein in p38-mediated mRNA stabilization | mRNA stability assays |
| ZFP36 | AU-rich element-binding protein family member linked to p38 pathway | Post-transcriptional regulation studies |
| MFA2 | AU-rich-element-bearing transcript regulated by p38/Hog1p | Translation control experiments |
| PCK1 | Gluconeogenic enzyme downstream of p38 signaling | Hepatic gluconeogenesis models |
| G6PC | Glucose-6-phosphatase downstream of p38 in liver | Metabolic p38 binding studies |
| DUSP1 | MAP kinase phosphatase that regulates p38 activity | Feedback regulation of p38 binding |
| MAP2K3 | Upstream kinase that activates p38 | Activation-dependent binding assays |
| MAP2K6 | Upstream kinase that activates p38 | Stress-induced p38 binding studies |
| MAP3K1 | Upstream MAP3K in p38 activation cascades | Signal transduction models |
How Is mitogen-activated protein kinase p38 binding Regulated?
p38 binding is regulated at multiple levels. Upstream MAP2K3 and MAP2K6 phosphorylate p38, and this activation changes the kinase surface available for partner engagement. Dynamic activation and regulation studies show that p38 undergoes conformational transitions that modulate binding. Phosphatases such as DUSP1 provide negative feedback that terminates p38 activity and indirectly limits binding events. In addition, subcellular localization regulates access to binding partners: keratins and Hsp70 control nuclear localization of p38, thereby determining where binding occurs. AU-rich element-binding proteins add another layer by coupling p38 pathway activity to mRNA stability and translation. Finally, small-molecule inhibitors that occupy the ATP pocket or adjacent surfaces can block p38 binding and downstream signaling, as reviewed in structure-activity studies.
mitogen-activated protein kinase p38 binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAPK14 | Inflammation and stress signaling | Knockout and point-mutation cell lines |
| HDAC4 | Skeletal development and chondrocyte hypertrophy | Hypertrophic chondrocyte models |
| PCK1 | Hepatic gluconeogenesis and metabolic disease | Liver cell overexpression models |
| ELAVL1 | mRNA stability in inflammation and cancer | AU-rich reporter assays |
| KRT8 | Epithelial stress and p38 localization | Keratin knockout epithelial cells |
Inflammation and stress-related disease
p38 MAP kinase is a stress-activated kinase, and its binding partners relay inflammatory and stress signals. AU-rich element-binding proteins involved in p38-mediated mRNA stabilization control the lifetime of transcripts encoding cytokines and other stress-response genes. Because p38 binding determines which transcripts are stabilized, dysregulation of GO:0048273 can contribute to chronic inflammation. p38 inhibitors have been developed with defined structure-activity relationships, underscoring the therapeutic relevance of the p38 binding interface.
Metabolic disease and hepatic gluconeogenesis
Cao et al. demonstrated that p38 MAP kinase plays a stimulatory role in hepatic gluconeogenesis. This links p38 binding events to glucose production in the liver, a process that is dysregulated in type 2 diabetes. Binding partners that couple p38 to gluconeogenic gene expression are therefore candidate targets for metabolic disease research.
Skeletal disease and chondrocyte biology
In hypertrophic chondrocytes, p38 induces HDAC4 degradation. HDAC4 is a key regulator of chondrocyte hypertrophy and skeletal development, so p38 binding events that promote its degradation can influence bone growth and osteoarthritis-related processes. This makes GO:0048273 relevant to skeletal biology and cartilage disease models.
Cancer and cell-fate control
p38 signaling influences cell proliferation, differentiation and survival, and its binding partners include AU-rich element-binding proteins that control oncogene and cytokine mRNA stability. Translation control via p38/Hog1p further shows that p38 binding can shape the proteome under stress. Because p38 inhibitors have been characterized in detail, the p38 binding interface is a plausible target for cancer and inflammation research, although disease-specific conclusions require further study.
From mitogen-activated protein kinase p38 binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of p38 binding alter stress-induced mRNA stability? | MAPK14 knockout cells with AU-rich reporter |
| Which residues mediate selective p38 partner binding? | Point-mutation knock-in of p38 docking surface |
| Does p38 binding control nuclear localization? | Tagged knock-in p38 with keratin/Hsp70 perturbation |
| Does p38 binding drive HDAC4 degradation? | Chondrocyte overexpression of HDAC4 and p38 mutants |
| Does p38 binding regulate gluconeogenic genes? | Hepatocyte overexpression and knockout models |
| Can inhibitors block p38 binding? | Recombinant p38 binding assays with small molecules |
How to Study the mitogen-activated protein kinase p38 binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Pull-down assay | Direct binding to p38 | Identify new p38 partners |
| Surface plasmon resonance | Binding affinity and kinetics | Quantify GO:0048273 interactions |
| Western blot | p38 phosphorylation status | Pathway activation studies |
| AU-rich reporter assay | mRNA stability | p38-mediated stabilization |
| Polysome profiling | Translation efficiency | AU-rich-element transcript control |
| Fluorescence microscopy | Subcellular localization of p38 | Keratin/Hsp70-dependent nuclear import |
| Inhibitor profiling | Blockade of p38 binding | Structure-activity studies |
Biochemical binding assays
Recombinant p38 MAP kinase, whose structure is known, can be used in pull-down, surface plasmon resonance and fluorescence polarization assays to measure binding to candidate partners. These assays are the most direct way to study GO:0048273 and can be adapted to test inhibitors with known structure-activity relationships.
Phosphorylation and signaling assays
Because p38 transfers phosphate from ATP to hydroxyl side chains on proteins, western blotting with phospho-specific antibodies measures downstream pathway activity. Dynamic activation and regulation of p38 can be tracked over time to correlate binding events with phosphorylation. Such assays are essential for linking GO:0048273 to functional outcomes.
RNA stability and translation assays
AU-rich element reporter assays measure how p38 binding partners affect mRNA stability. Polysome profiling or translation reporter systems can assess p38/Hog1p-dependent translation of AU-rich-element-bearing transcripts such as MFA2. These methods connect p38 binding to post-transcriptional control.
Imaging and localization studies
Fluorescence microscopy of tagged p38 can reveal nuclear translocation regulated by keratins and Hsp70. Localization studies are important because GO:0048273 binding events occur in specific cellular compartments. Combining imaging with binding assays provides spatial and biochemical resolution.
How CRISPR Can Be Used to Study GO:0048273 mitogen-activated protein kinase p38 binding
Knockout
CRISPR knockout of MAPK14 or of candidate binding partners removes the protein and allows researchers to test whether GO:0048273 is required for stress-induced mRNA stabilization, translation control or metabolic gene expression. Knockout cells are also useful for validating inhibitor specificity in the absence of p38.
Point Mutation
Point-mutation knock-in of residues in the p38 docking surface can dissect which contacts mediate selective binding. Such models are ideal for separating binding from catalytic activity, because a kinase-dead or docking-deficient mutant can be compared with wild-type p38 in the same cellular background.
Knock-in
Tagged knock-in of p38 or its partners enables localization and interaction studies in a physiological context. Knock-in reporters can also be used to monitor AU-rich element-dependent mRNA stability in real time. These models preserve endogenous regulation of GO:0048273.
Overexpression
Overexpression of p38, HDAC4 or AU-rich element-binding proteins can amplify binding-dependent phenotypes such as HDAC4 degradation in chondrocytes or gluconeogenic gene induction in hepatocytes. Overexpression systems are also convenient for biochemical purification of p38 complexes for binding assays.
How EDITGENE Supports mitogen-activated protein kinase p38 binding Research
Researchers studying mitogen-activated protein kinase p38 binding-related genes often need to determine whether a candidate gene is causally involved in stress signaling, mRNA stability or metabolic control. EDITGENE provides CRISPR-engineered cell models and screening services that let you move from correlation to causation with publication-ready validation.
Contact EDITGENE today to design your custom CRISPR model for mitogen-activated protein kinase p38 binding research.
Frequently Asked Questions About mitogen-activated protein kinase p38 binding
What is GO:0048273?
GO:0048273 is the Gene Ontology molecular function term for mitogen-activated protein kinase p38 binding, defined as binding to p38 MAP kinase, an enzyme that transfers phosphate from ATP to hydroxyl side chains on proteins in response to mitogen activation.
What genes are involved in mitogen-activated protein kinase p38 binding?
Key genes include MAPK14 encoding p38 alpha, other p38 family members MAPK11, MAPK12 and MAPK13, and binding partners such as HSPA1A, KRT8, KRT18, HDAC4 and AU-rich element-binding proteins.
Why is p38 binding important in disease?
p38 binding controls stress and inflammatory mRNA stability, hepatic gluconeogenesis and chondrocyte HDAC4 degradation, linking it to inflammation, metabolic disease and skeletal biology.
How is p38 MAP kinase structured?
The crystal structure of p38 MAP kinase revealed a bilobal kinase fold with an ATP-binding cleft and docking surfaces that mediate partner recognition.
Is p38 binding regulated dynamically?
Yes, dynamic activation and regulation studies show that p38 undergoes conformational changes that modulate binding to partners.
What proteins bind p38 to stabilize mRNA?
AU-rich element-binding proteins are involved in p38 pathway-mediated mRNA stabilization, and p38/Hog1p regulates translation of AU-rich-element-bearing transcripts such as MFA2.
How does p38 binding affect the nucleus?
Keratins regulate Hsp70-mediated nuclear localization of p38, showing that binding interactions control where p38 accumulates.
Can p38 binding be targeted by drugs?
Yes, structure-activity relationships of p38 inhibitors have been reviewed, and the p38 binding interface is a validated drug target.
What experimental models study p38 binding?
Recombinant binding assays, knockout and point-mutation cell lines, tagged knock-in imaging models and overexpression systems are commonly used.
Does p38 binding affect metabolism?
p38 MAP kinase plays a stimulatory role in hepatic gluconeogenesis, so p38 binding events influence metabolic gene expression.
Conclusion
GO:0048273, mitogen-activated protein kinase p38 binding, defines the molecular recognition events that position substrates, scaffolds and regulators on the stress-activated p38 kinase. Verified literature shows that these binding events control mRNA stabilization, translation of AU-rich-element transcripts, nuclear localization of p38, HDAC4 degradation in chondrocytes and hepatic gluconeogenesis, while the p38 structure and inhibitor landscape provide a framework for therapeutic intervention. Because p38 binding is dynamic and context-dependent, rigorous mechanistic studies require precise genetic models. CRISPR knockout, point-mutation, knock-in and overexpression cell lines, combined with biochemical binding assays and bioinformatics, offer a direct path to causal insight into GO:0048273 and its disease relevance.
References
- 1. Dean JL et al.. 2004. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation.. Cell Signal 16(10):1113-21 PMID: 15240006
- 2. Zhou J et al.. 2015. Mitogen-activated protein kinase p38 induces HDAC4 degradation in hypertrophic chondrocytes.. Biochim Biophys Acta 1853(2):370-376 PMID: 25447540
- 3. Bolós J. 2005. Structure-activity relationships of p38 mitogen-activated protein kinase inhibitors.. Mini Rev Med Chem 5(9):857-68 PMID: 16178727
- 4. Cao W et al.. 2005. p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis.. J Biol Chem 280(52):42731-7 PMID: 16272151
- 5. Lee SY et al.. 2019. Keratins regulate Hsp70-mediated nuclear localization of p38 mitogen-activated protein kinase.. J Cell Sci 132(18) PMID: 31427430
- 6. Kumar GS et al.. 2018. Dynamic activation and regulation of the mitogen-activated protein kinase p38.. Proc Natl Acad Sci U S A 115(18):4655-4660 PMID: 29666261
- 7. Vasudevan S et al.. 2005. p38 mitogen-activated protein kinase/Hog1p regulates translation of the AU-rich-element-bearing MFA2 transcript.. Mol Cell Biol 25(22):9753-63 PMID: 16260593
- 8. Wilson KP et al.. 1996. Crystal structure of p38 mitogen-activated protein kinase.. J Biol Chem 271(44):27696-700 PMID: 8910361
